Patent details

EP2849792 Title: LIQUID FORMULATION

Basic Information

Publication number:
EP2849792
PCT Application Number:
AU2013000522
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137914552
PCT Publication Number:
WO2013170317
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
LIQUID FORMULATION
French Title of Invention:
FORMULATION LIQUIDE
German Title of Invention:
FLÜSSIGKEITSFORMULIERUNG
SPC Number:

Dates

Filing date:
17/05/2013
Grant date:
04/03/2020
EP Publication Date:
25/03/2015
PCT Publication Date:
21/11/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/03/2020
EP B1 Publication Date:
04/03/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/05/2020
Expiration date:
17/05/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/02/2020
 
 

Name:
Luoda Pharma Limited
Address:
Lvl 2, 134/135 Baggot Street Lower, Dublin 2, Ireland (IE)

Inventor

1

Name:
BOVA, Nicholas
Address:
Australia (AU)

2

Name:
PIPPIA, Giuseppe
Address:
Australia (AU)

3

Name:
PAGE, Stephen
Address:
Australia (AU)

Priority

Priority Number:
2012902062
Priority Date:
18/05/2012
Priority Country:
Australia (AU)

Classification

IPC classification:
A61K 9/08; A61K 31/401; A61K 31/4184; A61P 9/10; A61K 47/10;

Publication

European Patent Bulletin

1

Issue number:
202010
Publication date:
04/03/2020
Description:
Grant (B1)

2

Issue number:
202015
Publication date:
08/04/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages